DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seung-Jun Kim | - |
dc.contributor.author | D H Kim | - |
dc.contributor.author | J D Park | - |
dc.contributor.author | Joo Rang Woo | - |
dc.contributor.author | Y H Jin | - |
dc.contributor.author | Seong Eon Ryu | - |
dc.date.accessioned | 2017-04-19T08:59:50Z | - |
dc.date.available | 2017-04-19T08:59:50Z | - |
dc.date.issued | 2003 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | 10.1016/S0968-0896(03)00140-8 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/6111 | - |
dc.description.abstract | Optically active N-formyl-N-hydroxy-α-phenylalanine methylamide (1) and N-formyl-N-hydroxy-β-phenylalanine methylamide (2) were evaluated as inhibitors for thermolysin (TLN) to find that while the D-form is more potent than its enantiomer in the case of the hydroxamate of α-Phe-NHMe, in the inhibition with hydroxamate of β-Phe-NHMe, the L-isomer (Ki=1.66±0.05 μM) is more effective than its enantiomer. In order to shed light on the stereochemical preference observed in the inhibitions, X-ray crystallographic analyses of the crystalline TLN·D-1 and TLN·L-2 complexes were performed to the resolution of 2.1 ?. While L-2 binds TLN like substrate does with its benzyl aromatic ring occupying the S1′ pocket, the electron density in the S1′ pocket in the complex of TLN·D-1 is weak and could best be accounted for by the methylcarbamoyl moiety. For both inhibitors, the hydroxamate moiety coordinates the active site zinc ion in a bidentate fashion. | - |
dc.publisher | Elsevier | - |
dc.title | Origin of the stereospecificity in binding hydroxamates of α- and β-phenylalanine methylamide to thermolysin revealed by the X-ray crystallographic study | - |
dc.title.alternative | Origin of the stereospecificity in binding hydroxamates of α- and β-phenylalanine methylamide to thermolysin revealed by the X-ray crystallographic study | - |
dc.type | Article | - |
dc.citation.title | Bioorganic & Medicinal Chemistry | - |
dc.citation.number | 11 | - |
dc.citation.endPage | 2426 | - |
dc.citation.startPage | 2421 | - |
dc.citation.volume | 11 | - |
dc.contributor.affiliatedAuthor | Seung-Jun Kim | - |
dc.contributor.affiliatedAuthor | Joo Rang Woo | - |
dc.contributor.affiliatedAuthor | Seong Eon Ryu | - |
dc.contributor.alternativeName | 김승준 | - |
dc.contributor.alternativeName | 김동 | - |
dc.contributor.alternativeName | 박정대 | - |
dc.contributor.alternativeName | 우주랑 | - |
dc.contributor.alternativeName | 진용호 | - |
dc.contributor.alternativeName | 류성언 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry, vol. 11, no. 11, pp. 2421-2426 | - |
dc.identifier.doi | 10.1016/S0968-0896(03)00140-8 | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.